PM

Professor Mattick

Healius Limited | Non-Executive Director
Professor Mattick is a member of the Risk Management Committees. John is a Professor in the School of Biotechnology and Biomolecular Science at UNSW Sydney. He was Chief Executive of Genomics England and Executive Director of the Garvan Institute of Medical Research. He was a member of the Australian Health Ethics Committee of the National Health & Medical Research Council, an advisor to the Australian Law Reform Commission's Inquiry into the Protection of Human Genetic Information and Gene Patenting & Human Health.

Company and Role

Company
Title
Tenure
Since
HLS
Healius Limited
  • Non-Executive Director
2yrs, 10mthMar 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
HLS
Healius Limited
30/06/244,13650,181N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
HLS
Healius Limited
14/05/24
Transfer
15,093$1.340$20,224As advised by the company
HLS
Healius Limited
14/05/24
Transfer
15,093$1.340$20,224As advised by the company
HLS
Healius Limited
14/12/23
Issued
7,546$1.200$9,055Rights issue
HLS
Healius Limited
14/12/23
Issued
4,136$1.200$4,963Rights issue
HLS
Healius Limited
04/09/23
Buy
7,547$3.313$25,000Conversion of securities